2026 Sponsors & Exhibitors

Centogene is a leading company in the field of genetic diagnostics and precision medicine, dedicated to transforming clinical, genetic, and biochemical data into medical solutions for patients. Based in Rostock, Germany, the company operates...

Founded in 2006, Staatz Consulting is a strategic and operational partner in Business Development and Market Access consulting, working with a broad client basis from the international (USA, Europe, Asia) biotechnology, pharmaceutical, medtech and...

Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. Chiesi Global Rare Diseases is a business unit of the Chiesi...

ICON plc is a world-leading clinical research organisation. Offering deep operational and medical expertise we accelerate innovation, driving emerging therapies forward to improve patient outcomes. From molecule to medicine, we deliver integrated...

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our...

Founded in 1997, Ergomed is a full-service, global Phase I-IV clinical development and trial management service partner with leading expertise in developing oncology and rare disease drugs. Ergomed’s proven delivery record, expertise, and true...

PANTHERx Rare Pharmacy makes rare disease care more personal and less overwhelming, focusing relentlessly on each patient and each therapy. Since its founding in a garage in Pittsburgh, PA in 2011, PANTHERx has grown into the largest independent...

Alchemist Consulting Ltd At Alchemist, we transform pharmaceutical and healthcare compliance. We deliver – handling everything from medical signatory work to technical reviews and compliant content creation. Our senior team seamlessly integrates...

The European FH Patient Network actively working to improve Europe-wide awareness, understanding, and access to diagnosis and treatment of inherited lipid conditions, (specifically FH, HoFH, Lp(a), FCS), so that all those impacted receive optimal...

Granzer Regulatory Consulting & Services offers support in all phases of drug and device development. From defining the right development strategy to submitting a marketing authorisation application, all the way through to approval and...

Pathways to Trust focuses on advocating for rare disease patients and improving access to care. They aim to eliminate biases in healthcare by fostering collaboration among patients, healthcare providers, and advocates. The organization provides...

Genontech is a Hungarian digital health startup building intelligent, interoperable platforms for healthcare institutions, research organisations and life-science partners. We do not treat patients ourselves. We help the professionals who do. Our...

Infirmacea Inc. is a preclinical-stage biotechnology company developing DNA medicines designed to make gene therapy safer, more accessible, and scalable. Founded in Japan, Infirmacea combines proprietary gene-expression technology with non-viral DNA ...

Nixi for Children is a Barcelona-based health innovation company that helps children and families prepare for medical procedures through immersive, child-friendly educational experiences. We combine virtual reality, medical plush toys and digital...

ONESTX leverages the biology of aging to treat incurable neurodegenerative conditions. Our lead oral compound, LON-21, restores the brain's youthful neurosteroid profile by irreversibly inhibiting the STS enzyme, driving neuroprotection and...

OpalMedica is a UK-based medical technology company focused on reducing the diagnostic delays experienced by people living with rare and underdiagnosed diseases. Founded by Sara Elgott, whose 30-year career has been dedicated to improving outcomes...

PatientGroups.co helps people discover trusted patient advocacy organisations worldwide, making it easier to find support, resources, and meaningful connections.

We are a health data and evidence-enablement platform in the making – designed to support the generation of patient-centric, HTA-ready real-world evidence in a secure and compliant manner. Our platform addresses a key structural challenge in health...

Unravel Biosciences is a clinical-stage therapeutics company that combines AI-driven systems biology with rapid clinical validation of newly discovered targets. Unravel leverages its proprietary BioNAV™ platform and primary transcriptomic data to...